help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roca, J.
Right arrow Articles by Rodriguez-Roisin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roca, J.
Right arrow Articles by Rodriguez-Roisin, R.

Am. J. Respir. Crit. Care Med., Vol 151, No. 6, Jun 1995, 1740-1744.

Salbutamol inhibits pulmonary effects of platelet activating factor in man

J Roca, MA Felez, KF Chung, JA Barbera, M Rotger, C Santos and R Rodriguez-Roisin
Servei de Pneumologia i Al.lergia Respiratoria, Hospital Clinic, Barcelona, Spain.

Inhaled platelet-activating factor (PAF) provokes considerable pulmonary gas exchange disturbances in normal man and in patients with mild asthma, similar to those observed in acute severe asthma. To further examine the mechanisms involved in PAF-induced ventilation- perfusion (VA/Q) mismatch, eight healthy, non-atopic, nonsmoking subjects were studied after administration of PAF aerosol (24 micrograms). They had been previously treated with inhaled salbutamol (300 micrograms) in a randomized, double-blind, cross-over, placebo- controlled design. After placebo, PAF provoked a fall in total arterial white cell count with a rebound leukocytosis. As shown in a previous study, an overall index of VA/Q inequality (DISP R-E*, 1.64 +/- 0.10) showed a threefold increase (P < 0.006) that accounted for the increase (79%) in AaPO2 (p < 0.04) after PAF, while the respiratory system resistance (Rrs) rose by 16% (p < 0.02). In contrast, after pretreatment with salbutamol inhaled PAF had no effects on pulmonary gas exchange, Rrs, or white cell count; facial flushing and cough were also hindered. The results are consistent with the hypothesis that salbutamol inhibits PAF-induced venoconstriction in both the airway and pulmonary microcirculation.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
H. A. Manrique, F. P. Gomez, P. A. Munoz, A. M. Pena, J. A. Barbera, J. Roca, and R. Rodriguez-Roisin
Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses
Eur. Respir. J., June 1, 2008; 31(6): 1205 - 1212.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Gabrijelcic, A. Casas, R.A. Rabinovich, J. Roca, J.A. Barbera, K.F. Chung, and R. Rodriguez-Roisin
Formoterol protects against platelet-activating factor-induced effects in asthma
Eur. Respir. J., January 1, 2004; 23(1): 71 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
O. DAZ, J. A. BARBER, R. MARRADES, K. CHUNG, J. ROCA, and R. RODRIGUEZ-ROISIN
Inhibition of PAF-induced Gas Exchange Defects by Beta-adrenergic Agonists in Mild Asthma Is Not Due to Bronchodilation
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 17 - 22.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. M. MARRADES, J. ROCA, J. A. BARBERÁ, L. de JOVER, W. MACNEE, and R. RODRIGUEZ-ROISIN
Nebulized Glutathione Induces Bronchoconstriction in Patients with Mild Asthma
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 425 - 430.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society